The company reaffirmed its adjusted EBITDA outlook of $950M-$1.03B after reporting strong Q2 2026 performance.
Versigent raised its 2026 net sales outlook to a range of $9.4 billion to $9.6 billion, citing disciplined execution and customer value. The company maintained its adjusted EBITDA forecast at $950 million to $1.03 billion for the period.
The update follows a solid Q2 2026, with management attributing growth to operational agility and a focus on execution. Prior guidance had not been disclosed in the latest release, but the revision reflects confidence in sustained momentum.
No immediate market reaction was detailed in the source.